Ligand Pharmaceuticals' Q3 2024 earnings report beat on the top and bottom lines, reinforcing my confidence. Read what makes ...

Ligand Pharmaceuticals (NASDAQ:LGND) is scheduled to announce Q3 earnings results on Thursday, November 7th, before market ...

Researchers have developed a ligand-protected direct hydrogen reduction strategy to prepare zeolite-confined Pt-Pd bimetallic ...

Shareholders were pleased with the recent earnings report from Ligand Pharmaceuticals Incorporated ( NASDAQ:LGND... JUPITER, Fla., November 14, 2024--Ligand Pharmaceuticals Incorporated (Nasdaq ...

A research team at the Institute of Materials Chemistry at TU Wien, led by Professor Dominik Eder, has developed a new ...

In a report released today, Balaji Prasad from Barclays assigned a Buy rating to Ligand Pharma (LGND – Research Report), with a price target of ...

Today we will run through one way of estimating the intrinsic value of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) by taking the expected future cash flows and discounting them to today's value.

At this time, I would like to welcome everyone to the Ligand's Third Quarter 2024 Earnings Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks ...

JUPITER, Fla.--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today reported financial results for the three and nine months ended September 30, 2024, and provided an ...

JUPITER, Fla., November 14, 2024--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that ...

Researchers developed SNIPRs, innovative receptors that sense soluble ligands, enabling precise therapeutic control in CAR ...